Protara Therapeutics's total assets for Q4 2025 were $209.47M, an increase of 44.82% from the previous quarter. TARA total liabilities were $13.06M for the fiscal quarter, a 5.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.